These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7901382)

  • 1. HTLV-II/HIV-1 coinfection and risk for progression to AIDS among intravenous drug users.
    Visconti A; Visconti L; Bellocco R; Binkin N; Colucci G; Vernocchi L; Amendola M; Ciaci D
    J Acquir Immune Defic Syndr (1988); 1993 Nov; 6(11):1228-37. PubMed ID: 7901382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users.
    Page JB; Lai SH; Chitwood DD; Klimas NG; Smith PC; Fletcher MA
    Lancet; 1990 Jun; 335(8703):1439-41. PubMed ID: 1972217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
    Casoli C; Pilotti E; Bertazzoni U
    AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users.
    Hershow RC; Galai N; Fukuda K; Graber J; Vlahov D; Rezza G; Klein RS; Des Jarlais DC; Vitek C; Khabbaz R; Freels S; Zuckerman R; Pezzotti P; Kaplan JE
    J Infect Dis; 1996 Aug; 174(2):309-17. PubMed ID: 8699060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of retroviral infections on immune function in African-American intravenous drug users.
    Klimas NG; Page JB; Patarca R; Chitwood D; Morgan R; Fletcher MA
    AIDS; 1993 Mar; 7(3):331-5. PubMed ID: 8471194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS.
    Turci M; Pilotti E; Ronzi P; Magnani G; Boschini A; Parisi SG; Zipeto D; Lisa A; Casoli C; Bertazzoni U
    J Acquir Immune Defic Syndr; 2006 Jan; 41(1):100-6. PubMed ID: 16340481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTLV-I and HTLV-II infections among HIV-1 seropositive patients in Sao Paulo, Brazil.
    de Araujo AC; Casseb JS; Neitzert E; de Souza ML; Mammano F; Del Mistro A; De Rossi A; Chieco-Bianchi L
    Eur J Epidemiol; 1994 Apr; 10(2):165-71. PubMed ID: 7813694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2.
    Beilke MA; Theall KP; O'Brien M; Clayton JL; Benjamin SM; Winsor EL; Kissinger PJ
    Clin Infect Dis; 2004 Jul; 39(2):256-63. PubMed ID: 15307036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coinfection by HTLV-I/II is associated with an increased risk of strongyloidiasis and delay in starting antiretroviral therapy for AIDS patients.
    Brites C; Goyanna F; França LG; Pedroso C; Netto EM; Adriano S; Sampaio J; Harrington W
    Braz J Infect Dis; 2011; 15(1):6-11. PubMed ID: 21412582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among US intravenous drug users.
    Briggs NC; Battjes RJ; Cantor KP; Blattner WA; Yellin FM; Wilson S; Ritz AL; Weiss SH; Goedert JJ
    J Infect Dis; 1995 Jul; 172(1):51-8. PubMed ID: 7797946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-infection with HIV-1/HTLV-II and the risk of progression to AIDS and death. The Oslo HIV Cohort Study Group.
    Eskild A; Samdal HH; Heger B
    APMIS; 1996 Sep; 104(9):666-72. PubMed ID: 8972691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No proof of HTLV-I/II in intravenous drug abusers with a high rate of HIV-1 infection in central Thailand.
    Saguanwongse S; Muangpom A; Ruchusatsawat N; Wongcheree S; Warachit P; Miyamura K; Yamazaki S; Honda M
    Microbiol Immunol; 1996; 40(9):639-44. PubMed ID: 8908608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV/HTLV-II coinfection and CD4+ cell count controlling for plasma HIV viral load in injection drug users in Baltimore.
    Zhang H; Flynn C; Nelson KE; Chen W; Kawalski R; Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(4):397-8. PubMed ID: 9704951
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug users.
    Fernández-Cruz E; Desco M; Garcia Montes M; Longo N; Gonzalez B; Zabay JM
    AIDS; 1990 Oct; 4(10):987-94. PubMed ID: 1979743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory study of HIV-1 and HTLV-I/II coinfection.
    Beilke MA; Greenspan DL; Impey A; Thompson J; Didier PJ
    J Med Virol; 1994 Oct; 44(2):132-43. PubMed ID: 7852953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired ichthyosis in concomitant HIV-1 and HTLV-II infection: a new association with intravenous drug abuse.
    Kaplan MH; Sadick NS; McNutt NS; Talmor M; Coronesi M; Hall WW
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):701-8. PubMed ID: 8227542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of HTLV-I/II and HIV-1 among intravenous drug users in Detroit.
    Ognjan AF; Lewandowski CA; Belian BT; Burczak J; Markowitz N; Lee H; Saravolatz LD
    Henry Ford Hosp Med J; 1992; 40(1-2):131-5. PubMed ID: 1428966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression.
    Brites C; Sampalo J; Oliveira A
    AIDS Rev; 2009; 11(1):8-16. PubMed ID: 19290030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematological indices in a cohort of HTLV-I/II and HIV-1 infected intravenous drug users in New York City.
    Brown LS; Chu A; Lee H; Allain JP
    J Natl Med Assoc; 1991 Aug; 83(8):677-9. PubMed ID: 1956078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of CC-chemokine expression and downregulated levels of CCR5 during HIV-1/HTLV-1 and HIV-1/HTLV-2 coinfections.
    Oo Z; Barrios CS; Castillo L; Beilke MA
    J Med Virol; 2015 May; 87(5):790-7. PubMed ID: 25678365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.